Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Rheumatoid Arthritis

  Free Subscription


26.06.2017

2 Ann Rheum Dis
1 Arthritis Res Ther
5 Clin Exp Rheumatol
3 Clin Rheumatol
2 Intern Med
1 J Immunol
1 J Rheumatol
2 Lancet
2 Rheumatol Int


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Rheum Dis

  1. RUBBERT-ROTH A, Jacobs JWG, Bijlsma JWJ, Welsing PMJ, et al
    A disconnect between disease activity and functional ability already in patients with early rheumatoid arthritis, depending on large joint involvement.
    Ann Rheum Dis. 2017 Jun 23. pii: annrheumdis-2017-211485.
    PubMed     Text format    

  2. SMOLEN JS, Cohen SB, Tony HP, Scheinberg M, et al
    A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis.
    Ann Rheum Dis. 2017 Jun 21. pii: annrheumdis-2017-211281.
    PubMed     Text format     Abstract available


    Arthritis Res Ther

  3. CABRERA-VILLALBA S, Gomara MJ, Canete JD, Ramirez J, et al
    Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis.
    Arthritis Res Ther. 2017;19:141.
    PubMed     Text format     Abstract available


    Clin Exp Rheumatol

  4. AYDIN SZ, Gunal EK, Ozata M, Keskin H, et al
    Six-joint ultrasound in rheumatoid arthritis: a feasible approach for implementing ultrasound in remission.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available

  5. NICAISE C, Weichselbaum L, Schandene L, Gangji V, et al
    Phagocyte-specific S100A8/A9 is upregulated in primary Sjogren's syndrome and triggers the secretion of pro-inflammatory cytokines in vitro.
    Clin Exp Rheumatol. 2017;35:129-136.
    PubMed     Text format     Abstract available

  6. BIRT JA, Tan Y, Mozaffarian N
    Sjogren's syndrome: managed care data from a large United States population highlight real-world health care burden and lack of treatment options.
    Clin Exp Rheumatol. 2017;35:98-107.
    PubMed     Text format     Abstract available

  7. ATZENI F, Gianturco L, Colombo C, Ricci C, et al
    Can speckle tracking echocardiography detect subclinical left ventricular dysfunction in patients with primary Sjogren's syndrome?
    Clin Exp Rheumatol. 2017;35:173.
    PubMed     Text format     Abstract available

  8. ANGELOTTI F, Parma A, Cafaro G, Capecchi R, et al
    One year in review 2017: pathogenesis of rheumatoid arthritis.
    Clin Exp Rheumatol. 2017;35:368-378.
    PubMed     Text format     Abstract available


    Clin Rheumatol

  9. FASSIO A, Idolazzi L, Viapiana O, Benini C, et al
    In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls.
    Clin Rheumatol. 2017 Jun 20. doi: 10.1007/s10067-017-3734.
    PubMed     Text format     Abstract available

  10. SYNGLE A, Kaur S, Verma I, Syngle T, et al
    Cost-effective analysis of disease-modifying anti-rheumatic drugs in rheumatoid arthritis.
    Clin Rheumatol. 2017 Jun 21. doi: 10.1007/s10067-017-3725.
    PubMed     Text format     Abstract available

  11. HAN J, Geng Y, Deng X, Zhang Z, et al
    Risk factors of flare in rheumatoid arthritis patients with both clinical and ultrasonographic remission: a retrospective study from China.
    Clin Rheumatol. 2017 Jun 22. doi: 10.1007/s10067-017-3736.
    PubMed     Text format     Abstract available


    Intern Med

  12. YAMAKAWA H, Hagiwara E, Yamanaka Y, Ikeda S, et al
    A 16-year Follow-up Case of Interstitial Pneumonia with Systemic Sclerosis-rheumatoid Arthritis Overlap Syndrome.
    Intern Med. 2017;56:1557-1561.
    PubMed     Text format     Abstract available

  13. AZUMA N, Matsui K, Hashimoto N, Yoshikawa T, et al
    Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis.
    Intern Med. 2017;56:1585-1590.
    PubMed     Text format     Abstract available


    J Immunol

  14. VOGT LM, Talens S, Kwasniewicz E, Scavenius C, et al
    Activation of Complement by Pigment Epithelium-Derived Factor in Rheumatoid Arthritis.
    J Immunol. 2017 Jun 21. pii: ji1700018. doi: 10.4049/jimmunol.1700018.
    PubMed     Text format     Abstract available


    J Rheumatol

  15. ZAMORA NV, Christensen R, Goel N, Klokker L, et al
    Critical Outcomes in Longitudinal Observational Studies and Registries in Patients with Rheumatoid Arthritis: An OMERACT Special Interest Group Report.
    J Rheumatol. 2017 Jun 15. pii: jrheum.161108. doi: 10.3899/jrheum.161108.
    PubMed     Text format     Abstract available


    Lancet

  16. FLEISCHMANN R, Mysler E, Hall S, Kivitz AJ, et al
    Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.
    Lancet. 2017 Jun 15. pii: S0140-6736(17)31618.
    PubMed     Text format     Abstract available

  17. SCOTT DL, Stevenson MD
    Treating active rheumatoid arthritis with Janus kinase inhibitors.
    Lancet. 2017 Jun 15. pii: S0140-6736(17)31659.
    PubMed     Text format    


    Rheumatol Int

  18. MENA-VAZQUEZ N, Manrique-Arija S, Yunquera-Romero L, Urena-Garnica I, et al
    Adherence of rheumatoid arthritis patients to biologic disease-modifying antirheumatic drugs: a cross-sectional study.
    Rheumatol Int. 2017 Jun 19. doi: 10.1007/s00296-017-3758.
    PubMed     Text format     Abstract available

  19. HUSNI ME, Betts KA, Griffith J, Song Y, et al
    Benefit-risk trade-offs for treatment decisions in moderate-to-severe rheumatoid arthritis: focus on the patient perspective.
    Rheumatol Int. 2017 Jun 16. doi: 10.1007/s00296-017-3760.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: